Blue Foundry Bancorp Reports Fourth Quarter and Year-End 2023 Results
January 24, 2024 08:15 ET
|
Blue Foundry Bancorp
RUTHERFORD, N.J., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the “Company”), the holding company for Blue Foundry Bank (the “Bank”), today reported a net loss of $7.4...
Real Estate Split Corp. Class A Distribution
January 24, 2024 08:15 ET
|
Real Estate Split Corp.
TORONTO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Real Estate Split Corp. (TSX: RS) (the “Fund” is pleased to announce that a distribution for January 2024 will be payable to Class A shareholders of Real...
SVT-15473 Emerging Drug Analysis and Market Forecasts, 2019-2023 and 2023-2029: A New and Innovative Ocular Nano-Emulsion of Super-Potent Steroid Clobetasol Propionate
January 24, 2024 08:14 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "SVT-15473 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Global Market Insights...
Dog Collars, Leashes & Harnesses Market Set to Reach US$ 9.51 Billion by 2030 with an 8.2% CAGR | Persistence Market Research
January 24, 2024 08:13 ET
|
Persistence Market Research
New York, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The global dog collars, leashes & harnesses market is forecasted to expand at a CAGR of 8.2% and thereby increase from a value of US$5.47 Bn in 2023...
DEXCYU Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032: A Dexamethasone Intra-ocular Suspension Marketed for Treating Postoperative Inflammation
January 24, 2024 08:13 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "DEXCYU Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
K-321 (Ripasudil) for Fuchs Endothelial Corneal Dystrophy (FECD): Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032
January 24, 2024 08:12 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "K-321 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Atlanticus Announces Offering of Senior Notes
January 24, 2024 08:12 ET
|
Atlanticus Holdings Corp
ATLANTA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” “the Company”, “we,” “our” or “us”), a financial technology company that enables its bank,...
Intravenous Solutions Market to Surpass US$ 33.6 Billion by 2032 with a Projected 10.8% CAGR Over the Next Decade | Persistence Market Research
January 24, 2024 08:11 ET
|
Persistence Market Research
New York, Jan. 24, 2024 (GLOBE NEWSWIRE) -- In 2021, the global Intravenous Solutions Market was worth approximately US$ 10.9 billion. Predicted to grow at a rate of 10.8% per year for the next...
ONCOS-102: An Oncolytic Adenovirus with an Immune-Stimulating Transgene - Emerging Drug Analysis and Market Forecasts, 2019-2023 and 2023-2032 with Focus on 7 Major Markets
January 24, 2024 08:11 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "ONCOS-102 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Placements AGF annonce les distributions en espèces de janvier 2024 pour le Fonds de revenu amélioré d’actions américaines AGF et le FNB Actions mondiales Infrastructures – Approche systématique AGF
January 24, 2024 08:10 ET
|
La Société de Gestion AGF Limitée
TORONTO, 24 janv. 2024 (GLOBE NEWSWIRE) -- Placements AGF Inc. (« Placements AGF ») a annoncé aujourd’hui les distributions en espèces de janvier 2024, pour le *Fonds de revenu amélioré d’actions...
- August 06, 2024 16:15 ET GAMCO Investors, Inc. Reports Results for the 2nd Quarter 2024
- August 06, 2024 16:15 ET PlayAGS Stockholders Approve Acquisition By Brightstar Capital Partners